The London-based company is working with advisers to gauge interest from potential buyers, the people said, asking not to be named because the details aren’t public. Vitabiotics, which sells some of the UK’s most popular supplement brands including Wellwoman and Wellbaby, could be valued at about £1 billion ($1.2 billion) in a sale, the people said.
Consumer companies
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.